ISSN: 2375-4273
Lipoprotein(a) is a Prevalent yet Vastly Underrecognized Risk Factor for Cardiovascular Disease
Challenges For The Future Of Complementary And Integrative Care
View More »
Health Care : Current Reviews received 1283 citations as per Google Scholar report
Short Communication
Comparison of adverse effects among different GLP-1 receptor agonists added to basal insulin and between GLP-1 receptor agonists and basal Insulin versus basal-plus or basal-bolus insulin in type 2 diabetes
Diabetic kidney disease: Where are we and what does the future hold
Would it be advantageous utilizing beta cell therapies over immunotherapies for avoidance of type 1 diabetes - A systematic Review on the role of beta cells in etiopathogenesis of type 1 diabetes along with treatments targeting beta cells or combination therapy would be better
Cardiovascular aspects of the patients with diabetes
Metabolic clustering of risk factors: Evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance
Monitoring hypoglycemia and glycaemic variability through CGM devices in type 2 diabetes patients